Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis

BACKGROUND: WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. Few studies have compared resistance pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngo-Giang-Huong, Nicole, Jourdain, Gonzague, Amzal, Billy, Sang-a-gad, Pensiriwan, Lertkoonalak, Rittha, Eiamsirikit, Naree, Tansuphasawasdikul, Somboon, Buranawanitchakorn, Yuwadee, Yutthakasemsunt, Naruepon, Mekviwattanawong, Sripetcharat, McIntosh, Kenneth, Lallemant, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223170/
https://www.ncbi.nlm.nih.gov/pubmed/22132100
http://dx.doi.org/10.1371/journal.pone.0027427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223170/
https://www.ncbi.nlm.nih.gov/pubmed/22132100
http://dx.doi.org/10.1371/journal.pone.0027427

Ejemplares similares